ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

AVAH vs WGS // EV/EBITDA & P/E VALUATION

Aveanna Healthcare Holdings Inc. (NASDAQ) VS. GeneDx Holdings Corp. (Class A) (NASDAQ) • 15-METRIC TALLY: AVAH 6 — WGS 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVAH VS. WGS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC AVAH WGS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 33.30% 69.70% -36.40 WGS /gross-margins <GO>
Return on Invested Capital (ROIC) 15.70% -4.10% +19.80 AVAH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE 15.5x — — TIE /valuation <GO>
Free Cash Flow Yield 4.35% 0.67% +3.68 AVAH /fcf-yield <GO>
Operating Margin 10.50% -3.10% +13.60 AVAH /operating-margins <GO>
Net Profit Margin 0.00% -4.90% +4.90 AVAH /net-margins <GO>
Revenue Growth (YoY) 20.20% 40.00% -19.80 WGS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 1.86 3.32 -1.46 WGS /balance-sheet <GO>
Piotroski F-Score Quality 8/9 8/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 56.0 48.5 +7.51 AVAH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $2.89B $2.12B $775.6M AVAH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR AVAH REV WGS REV AVAH GROSS % WGS GROSS % AVAH FCF WGS FCF
FY 2025 $2.43B $427.5M 33.3% 69.7% $125.9M $14.3M
FY 2024 $2.02B $305.4M 31.4% 63.6% $32.6M -$34.0M
FY 2023 $1.90B $202.6M — — $22.7M -$180.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVAH // BETA —
WGS // BETA —